Search
for
Sort by
Research 301–330 of 1000+
- Raynaud Phenomenon
- Low fluence-high repetition rate diode laser hair removal 12-month evaluation: Reducing pain and risks while keeping clinical efficacy
- Targeted photochemotherapy in alopecia areata
- Dose‐response of human follicles during laser‐based hair removal: <i>Ex vivo</i> photoepilation model with classification system embracing morphological and histological features
- Avaliação do efeito do ácido piperonílico na cicatrização de feridas em camundongos
- Theoretical considerations in laser hair removal
- Treatment of trichostasis spinulosa with 0.5-millisecond pulsed 755-nm alexandrite laser
- Considerations on Hair Research and Hair Growth
- High-Performance Wigs via the Langmuir–Blodgett Deposition of Keratin/Graphene Oxide Nanocomposite
- TRASER: Acute phase vascular and follicular changes
- ALOPESİ AREATADA TOPİKAL PSORALEN VE ULTRAVİOLE A FOTOKEMOTERAPİSİNİN ETKİNLİĞİNİN DEĞERLENDİRİLMESİ
- Juvenile versus maturity-onset alopecia areata- a comparative retrospective clinical study
- 277 An open label pilot clinical trial of the JAK inhibitor tofacitinib for alopecia areata
- 331 An open label clinical trial of the JAK inhibitor tofacitinib for alopecia areata
- 0935 Unravelling the role of JAK3/TEC kinase signalling with ritlecitinib in alopecia areata lesional skin and alopecia areata-induced human hair follicles ex vivo
- 59 Scarring alopecia is driven by the collapse of EGFR-protected JAK-STAT1-sensitive stem cell immune privilege
- 69 Risk-benefit appraisal of systemic JAK inhibitors for alopecia areata: a comprehensive meta-analysis assessing safety and adverse effects
- 84 Partial restoration of scalp microbiota in alopecia areata with JAK inhibitors
- 1332 Janus kinase inhibitor increases hair growth by increasing beta-catenin activity in outer root sheath cells
- 705 Particulate matter induces inflammatory response in human outer root sheath cells via oxidative stress-dependent MAPK and JAK-STAT signaling pathways
- 706 Predictive modeling of patient response to JAK/STAT inhibitors and dynamic patient-matching
- 695 Selectively targeting JAK1 or JAK3 pathway is sufficient to reverse alopecia areata
- 917 Frontal fibrosing alopecia scalp profiling links Th1/Th2 and JAK3 activation with fibrosis and loss of follicular stem cells
- 692 Study of the impact of SKPs’ secreted factors and of a botanical extract derived from jasmine on keratinocytes growth and reconstructed human epidermis thickness
- 546 Gene expression signatures and ALADIN score correlates with response of alopecia areata patients to treatment with JAK inhibitors
- PUVA treatment of alopecia areata partialis, totalis and universalis: audit of 10 years' experience at St John's Institute of Dermatology
- The emerging role of Janus kinase inhibitors in the treatment of autoimmune and inflammatory diseases
- Topical minoxidil in alopecia areata: a double-blind trial
- Randomized Controlled Trial of the Topical Jak Inhibitor Delgocitinib Cream in Patients with Frontal Fibrosing Alopecia
- 62202 Network meta-analysis (NMA) of FDA-approved JAK inhibitors for alopecia areata (AA) with at least 50% hair loss per SALT score